Reportlinker Adds Taiwan In Vitro Diagnostics Market Outlook to 2016

Tuesday, July 20, 2010 Research News
Email Print This Page Comment


NEW YORK, July 19 Reportlinker.com announces that a new market research report is available in its catalogue:

Taiwan In Vitro Diagnostics Market Outlook to 2016

http://www.reportlinker.com/p0240269/Taiwan-In-Vitro-Diagnostics-Market-Outlook-to-2016.html

Taiwan In Vitro Diagnostics Market Outlook to 2016

Summary

GlobalData's new report, "Taiwan In Vitro Diagnostics Market Outlook to 2016" provides key market data on the Taiwan In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.

- 2009 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the Taiwan In Vitro Diagnostics (IVD) market.

- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Taiwan In Vitro Diagnostics (IVD) competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 12

2 Introduction 15

2.1 What is This Report About? 15

3 In Vitro Diagnostics In Taiwan 16

3.1 In Vitro Diagnostics, Market Segmentation 16

3.2 In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 17

3.3 In Vitro Diagnostics Market, Taiwan, Revenue Mix ($m), 2009 19

3.4 In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20

3.5 In Vitro Diagnostics, Taiwan, Company Share (2008-2009) 26

4 Clinical Chemistry In Taiwan 28

4.1 Clinical Chemistry, Market Segmentation 28

4.2 Clinical Chemistry Market, Taiwan, Revenue Mix ($m), 2009 29

4.3 Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30

4.4 Clinical Chemistry Overall Revenue (2002-2016) 31

4.4.1 Clinical Chemistry Analyzers Revenue (2002-2016) 35

4.4.2 Urine Analysis Revenue (2002-2016) 39

4.5 Clinical Chemistry Distribution Share (2008-2009) 43

4.6 Clinical Chemistry, Taiwan, Company Share (2008-2009) 44

5 Genetic Testing In Taiwan 46

5.1 Genetic Testing, Market Segmentation 46

5.2 Genetic Testing Market, Taiwan, Revenue Mix ($m), 2009 47

5.3 Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48

5.4 Genetic Testing Overall Revenue (2002-2016) 49

5.5 Genetic Testing Distribution Share (2008-2009) 53

5.6 Genetic Testing, Taiwan, Company Share (2008-2009) 54

6 Haematology In Taiwan 55

6.1 Haematology, Market Segmentation 55

6.2 Haematology Market, Taiwan, Revenue Mix ($m), 2009 56

6.3 Haematology Market, Taiwan, Category Contribution (%), 2009 57

6.4 Haematology Overall Revenue (2002-2016) 58

6.4.1 Haematology Reagents Revenue (2002-2016) 62

6.4.2 Immunohaematology Revenue (2002-2016) 65

6.4.3 Haemostasis Revenue (2002-2016) 67

6.4.4 Haematology Rapid Tests Revenue (2002-2016) 71

6.4.5 Haematology Cell Counters Revenue (2002-2016) 74

6.5 Haematology Distribution Share (2008-2009) 76

6.6 Haematology, Taiwan, Company Share (2008-2009) 77

7 Histology And Cytology In Taiwan 79

7.1 Histology and Cytology, Market Segmentation 79

7.2 Histology and Cytology Market, Taiwan, Revenue Mix ($m), 2009 80

7.3 Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81

7.4 Histology and Cytology Overall Revenue (2002-2016) 82

7.4.1 Histology Revenue (2002-2016) 85

7.5 Histology And Cytology Distribution Share (2008-2009) 88

7.6 Histology And Cytology, Taiwan, Company Share (2008-2009) 89

8 Immuno Chemistry In Taiwan 90

8.1 Immuno Chemistry, Market Segmentation 90

8.2 Immuno Chemistry Market, Taiwan, Revenue Mix ($m), 2009 91

8.3 Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92

8.4 Immuno Chemistry Overall Revenue (2002-2016) 93

8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 97

8.4.2 Drug Related Testing Revenue (2002-2016) 101

8.4.3 Endocrinology Tests Revenue (2002-2016) 103

8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 107

8.5 Immuno Chemistry Distribution Share (2008-2009) 111

8.6 Immuno Chemistry, Taiwan, Company Share (2008-2009) 112

9 Infectious Immunology In Taiwan 114

9.1 Infectious Immunology, Market Segmentation 114

9.2 Infectious Immunology Market, Taiwan, Revenue Mix ($m), 2009 115

9.3 Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116

9.4 Infectious Immunology Overall Revenue (2002-2016) 117

9.5 Infectious Immunology Distribution Share (2008-2009) 121

9.6 Infectious Immunology, Taiwan, Company Share (2008-2009) 122

10 Microbiology Culture In Taiwan 124

10.1 Microbiology Culture, Market Segmentation 124

10.2 Microbiology Culture Market, Taiwan, Revenue Mix ($m), 2009 125

10.3 Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126

10.4 Microbiology Culture Overall Revenue (2002-2016) 127

10.4.1 Microbiology Analyzers Revenue (2002-2016) 131

10.5 Microbiology Culture Distribution Share (2008-2009) 133

10.6 Microbiology Culture, Taiwan, Company Share (2008-2009) 134

11 Overview of Key Companies in Taiwan In Vitro Diagnostics Market 135

11.1 F. Hoffmann-La Roche Ltd. 135

11.1.1 Company Overview 135

11.1.2 Share in the Taiwan In Vitro Diagnostics Market 135

11.2 Siemens Healthcare 136

11.2.1 Company Overview 136

11.2.2 Share in the Taiwan In Vitro Diagnostics Market 136

11.3 Beckman Coulter, Inc. 137

11.3.1 Company Overview 137

11.3.2 Share in the Taiwan In Vitro Diagnostics Market 137

11.4 Ortho-Clinical Diagnostics Inc. 138

11.4.1 Company Overview 138

11.4.2 Share in the Taiwan In Vitro Diagnostics Market 138

11.5 Abbott Laboratories 139

11.5.1 Company Overview 139

11.5.2 Share in the Taiwan In Vitro Diagnostics Market 139

11.6 bioMerieux S.A. 140

11.6.1 Company Overview 140

11.6.2 Share in the Taiwan In Vitro Diagnostics Market 140

11.7 Inverness Medical Innovations, Inc. 141

11.7.1 Company Overview 141

11.8 Becton, Dickinson and Company 141

11.8.1 Company Overview 141

11.9 Bio-Rad Laboratories, Inc. 142

11.9.1 Company Overview 142

11.10 Hologic, Inc. 142

11.10.1 Company Overview 142

11.11 OLYMPUS CORPORATION 143

11.11.1 Company Overview 143

11.12 Mindray Medical International Limited 143

11.12.1 Company Overview 143

11.13 Sysmex Corporation 144

11.13.1 Company Overview 144

11.14 Ventana Medical Systems, Inc. 144

11.14.1 Company Overview 144

11.15 DiaSorin S.p.A 144

11.15.1 Company Overview 144

11.16 Qiagen N.V. 145

11.16.1 Company Overview 145

11.17 Gen-Probe Incorporated 145

11.17.1 Company Overview 145

11.18 Phadia AB 145

11.18.1 Company Overview 145

11.19 BioCare Corporation 146

11.19.1 Company Overview 146

11.20 AsiaGen Corporation 146

11.20.1 Company Overview 146

11.21 Oncoprobe Biotech Inc. 146

11.21.1 Company Overview 146

11.22 Exploit Technologies Pte Ltd 147

11.22.1 Company Overview 147

11.23 Apex Biotechnology Corp. 147

11.23.1 Company Overview 147

11.24 Health & Life Co., Ltd. 147

11.24.1 Company Overview 147

11.25 Eumed Biotechnology Co., Ltd. 148

11.25.1 Company Overview 148

11.26 Vita Genomics, Inc. 148

11.26.1 Company Overview 148

11.27 Formosa Biomedical Technology Corp. 148

11.27.1 Company Overview 148

12 In Vitro Diagnostics Market Pipeline Products 149

12.1 Clinical Chemistry Market Pipeline Products 149

12.2 Immuno Chemistry Market Pipeline Products 151

12.3 Haematology Market Pipeline Products 152

12.4 Infectious Immunology Market Pipeline Products 153

12.5 Microbiology Culture Market Pipeline Products 155

12.6 Histology and Cytology Market Pipeline Products 156

12.7 Genetic Testing Market Pipeline Products 157

13 Financial Deals Landscape 159

13.1 Partnerships 159

13.1.1 QIAGEN Enters Into Distribution Agreement With Celera 159

13.1.2 Sequenom Enters Into Licensing Agreement With Optherion 160

13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 161

13.1.4 TriLink BioTechnologies Enters Into Distribution Agreement With Nacalai USA 162

13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 163

13.1.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 164

13.1.7 DxS Signs Cross-Licensing Agreement With Epigenomics 165

14 Appendix 166

14.1 Definitions of Markets Covered in the Report 167

14.1.1 In Vitro Diagnostics 167

14.2 Research Methodology 174

14.3 Secondary Research 175

14.4 Primary Research 175

14.5 Models 176

14.6 Forecasts 176

14.7 Expert Panels 176

14.8 GlobalData Consulting 176

14.9 Currency Conversion 177

14.10 Contact Us 177

14.11 Disclaimer 177

1.1 List of Tables

Table 1: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 18

Table 2: In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20

Table 3: In Vitro Diagnostics, Taiwan, Cross-Category Analysis, 2002-2016 21

Table 4: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Historic, 2002-2009 23

Table 5: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Forecast, 2009-2016 25

Table 6: In Vitro Diagnostics, Taiwan, Company Share by Revenue ($m), 2008-2009 27

Table 7: Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30

Table 8: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 32

Table 9: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 34

Table 10: Clinical Chemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 36

Table 11: Clinical Chemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 38

Table 12: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40

Table 13: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42

Table 14: Clinical Chemistry, Taiwan, Distribution Share by Revenue ($m), 2008-2009 43

Table 15: Clinical Chemistry, Taiwan, Company Share by Revenue ($m), 2008-2009 45

Table 16: Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48

Table 17: Genetic Testing, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 50

Table 18: Genetic Testing, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 52

Table 19: Genetic Testing, Taiwan, Distribution Share by Revenue ($m), 2008-2009 53

Table 20: Genetic Testing, Taiwan, Company Share by Revenue ($m), 2008-2009 54

Table 21: Haematology Market, Taiwan, Category Contribution (%), 2009 57

Table 22: Haematology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 59

Table 23: Haematology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 61

Table 24: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63

Table 25: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64

Table 26: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 65

Table 27: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 66

Table 28: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 68

Table 29: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 70

Table 30: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71

Table 31: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73

Table 32: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74

Table 33: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 75

Table 34: Haematology, Taiwan, Distribution Share by Revenue ($m), 2008-2009 76

Table 35: Haematology, Taiwan, Company Share by Revenue ($m), 2008-2009 78

Table 36: Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81

Table 37: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 83

Table 38: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 84

Table 39: Histology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 86

Table 40: Histology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 87

Table 41: Histology And Cytology, Taiwan, Distribution Share by Revenue ($m), 2008-2009 88

Table 42: Histology And Cytology, Taiwan, Company Share by Revenue ($m), 2008-2009 89

Table 43: Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92

Table 44: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 94

Table 45: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 96

Table 46: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 98

Table 47: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 100

Table 48: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 101

Table 49: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 102

Table 50: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 104

Table 51: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 106

Table 52: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 108

Table 53: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 110

Table 54: Immuno Chemistry, Taiwan, Distribution Share by Revenue ($m), 2008-2009 111

Table 55: Immuno Chemistry, Taiwan, Company Share by Revenue ($m), 2008-2009 113

Table 56: Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116

Table 57: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 118

Table 58: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 120

Table 59: Infectious Immunology, Taiwan, Distribution Share by Revenue ($m), 2008-2009 121

Table 60: Infectious Immunology, Taiwan, Company Share by Revenue ($m), 2008-2009 123

Table 61: Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126

Table 62: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 128

Table 63: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 130

Table 64: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 131

Table 65: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 132

Table 66: Microbiology Culture, Taiwan, Distribution Share by Revenue ($m), 2008-2009 133

Table 67: Microbiology Culture, Taiwan, Company Share by Revenue ($m), 2008-2009 134

Table 68: Clinical Chemistry Market Pipeline Products 149

Table 69: Immuno Chemistry Market Pipeline Products 151

Table 70: Haematology Market Pipeline Products 152

Table 71: Infectious Immunology Market Pipeline Products 153

Table 72: Microbiology Culture Market Pipeline Products 155

Table 73: Histology and Cytology Market Pipeline Products 156

Table 74: Genetic Testing Market Pipeline Products 157

Table 75: QIAGEN Enters Into Distribution Agreement With Celera 159

Table 76: Sequenom Enters Into Licensing Agreement With Optherion 160

Table 77: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 161

Table 78: TriLink BioTechnologies Enters Into Distribution Agreement With Nacalai USA 162

Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 163

Table 80: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 164

Table 81: DxS Signs Cross-Licensing Agreement With Epigenomics 165

Table 82: USD to Local Currency, Taiwan, Average Actual Rate 2002-2009 177

1.2 List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 16

Figure 2: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 17

Figure 3: In Vitro Diagnostics Market, Taiwan, Revenue Mix ($m), 2009 19

Figure 4: In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20

Figure 5: In Vitro Diagnostics, Taiwan, Cross-Category Analysis, 2002-2016 21

Figure 6: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Historic, 2002-2009 22

Figure 7: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Forecast, 2009-2016 24

Figure 8: In Vitro Diagnostics, Taiwan, Company Share (%), 2009 26

Figure 9: Clinical Chemistry, Market Segmentation 28

Figure 10: Clinical Chemistry Market, Taiwan, Revenue Mix ($m), 2009 29

Figure 11: Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30

Figure 12: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 31

Figure 13: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 33

Figure 14: Clinical Chemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35

Figure 15: Clinical Chemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37

Figure 16: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39

Figure 17: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41

Figure 18: Clinical Chemistry, Taiwan, Company Share (%), 2009 44

Figure 19: Genetic Testing, Market Segmentation 46

Figure 20: Genetic Testing Market, Taiwan, Revenue Mix ($m), 2009 47

Figure 21: Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48

Figure 22: Genetic Testing, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 49

Figure 23: Genetic Testing, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 51

Figure 24: Genetic Testing, Taiwan, Company Share (%), 2009 54

Figure 25: Haematology, Market Segmentation 55

Figure 26: Haematology Market, Taiwan, Revenue Mix ($m), 2009 56

Figure 27: Haematology Market, Taiwan, Category Contribution (%), 2009 57

Figure 28: Haematology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 58

Figure 29: Haematology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 60

Figure 30: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62

Figure 31: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64

Figure 32: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 65

Figure 33: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 66

Figure 34: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67

Figure 35: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69

Figure 36: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71

Figure 37: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72

Figure 38: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74

Figure 39: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 75

Figure 40: Haematology, Taiwan, Company Share (%), 2009 77

Figure 41: Histology and Cytology, Market Segmentation 79

Figure 42: Histology and Cytology Market, Taiwan, Revenue Mix ($m), 2009 80

Figure 43: Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81

Figure 44: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 82

Figure 45: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 84

Figure 46: Histology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 85

Figure 47: Histology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 87

Figure 48: Histology And Cytology, Taiwan, Company Share (%), 2009 89

Figure 49: Immuno Chemistry, Market Segmentation 90

Figure 50: Immuno Chemistry Market, Taiwan, Revenue Mix ($m), 2009 91

Figure 51: Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92

Figure 52: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 93

Figure 53: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 95

Figure 54: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 97

Figure 55: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 99

Figure 56: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 101

Figure 57: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 102

Figure 58: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 103

Figure 59: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 105

Figure 60: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107

Figure 61: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 109

Figure 62: Immuno Chemistry, Taiwan, Company Share (%), 2009 112

Figure 63: Infectious Immunology, Market Segmentation 114

Figure 64: Infectious Immunology Market, Taiwan, Revenue Mix ($m), 2009 115

Figure 65: Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116

Figure 66: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 117

Figure 67: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 119

Figure 68: Infectious Immunology, Taiwan, Company Share (%), 2009 122

Figure 69: Microbiology Culture, Market Segmentation 124

Figure 70: Microbiology Culture Market, Taiwan, Revenue Mix ($m), 2009 125

Figure 71: Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126

Figure 72: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 127

Figure 73: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 129

Figure 74: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 131

Figure 75: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 132

Figure 76: Microbiology Culture, Taiwan, Company Share (%), 2009 134

Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 135

Figure 78: Siemens Healthcare, Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 136

Figure 79: Beckman Coulter, Inc., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 137

Figure 80: Ortho-Clinical Diagnostics Inc., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 138

Figure 81: Abbott Laboratories, Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 139

Figure 82: bioMerieux S.A., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 140

Figure 83: GlobalData Methodology 174

Companies mentioned F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Beckman Coulter, Inc.

Ortho-Clinical Diagnostics Inc.

Abbott Laboratories

bioMerieux S.A.

Inverness Medical Innovations, Inc.

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc.

Hologic, Inc.

OLYMPUS CORPORATION

Mindray Medical International Limited

Sysmex Corporation

Ventana Medical Systems, Inc.

DiaSorin S.p.A

Qiagen N.V.

Gen-Probe Incorporated

Phadia AB

BioCare Corporation

AsiaGen Corporation

Oncoprobe Biotech Inc.

Exploit Technologies Pte Ltd

Apex Biotechnology Corp.

Health & Life Co., Ltd.

Eumed Biotechnology Co., Ltd.

Vita Genomics, Inc.

Formosa Biomedical Technology Corp.

To order this report:

In Vitro Diagnostic Industry: Taiwan In Vitro Diagnostics Market Outlook to 2016

In Vitro Diagnostic Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook